Franklin Biotechnology Discovery Fund Investor Sentiment

FRBRX Fund  USD 132.25  1.73  1.33%   
Slightly above 50% of Franklin Biotechnology's investors are presently thinking to get in. The analysis of overall sentiment of trading Franklin Biotechnology Discovery mutual fund suggests that some investors are interested at this time. Franklin Biotechnology's investing sentiment can be driven by a variety of factors including economic data, Franklin Biotechnology's earnings reports, geopolitical events, and overall market trends.
  
over two months ago at news.google.com         
Franklin Biotechnology Discovery Fund Q3 2024 Commentary - Seeking Alpha
Google News at Macroaxis
over three months ago at news.google.com         
Franklin Biotechnology Discovery Fund Q2 2024 Commentary - Seeking Alpha
Google News at Macroaxis
3 days ago at finance.yahoo.com         
Disposition of 429 shares by Michael Morrissey of Incyte at 73.47 subject to Rule 16b-3
Yahoo News
few days ago at thelincolnianonline.com         
Incyte Co. Shares Bought by Hennion Walsh Asset Management Inc.
news
over a week ago at kalkinemedia.com         
Innovent Receives NMPA Breakthrough Therapy Designation for IBI343 as Monotherapy for Advanced Pancr...
news
over a week ago at seekingalpha.com         
Incyte, Syndax get FDA okay for 9 mg, 22 mg Niktimvo vials
seekingalpha News
over a week ago at finance.yahoo.com         
Has Incyte Outpaced Other Medical Stocks This Year?
Yahoo News
over a week ago at thelincolnianonline.com         
Incyte Given Neutral Rating at Cantor Fitzgerald
news
over a week ago at zacks.com         
INCY vs. VRTX Which Stock Is the Better Value Option?
zacks News
over two weeks ago at finance.yahoo.com         
Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635
Yahoo News
over two weeks ago at businesswire.com         
Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635
businesswire News
over two weeks ago at finance.yahoo.com         
Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635
Yahoo News
over a year ago at finance.yahoo.com         
Orphan Drug Market Size Share to Surpass 3199.3 Billion by 2028 Vantage Market Research
Yahoo News
six days ago at zacks.com         
Array Technologies, Inc. Stock Sinks As Market Gains What You Should Know
zacks News
over two weeks ago at finance.yahoo.com         
Is Array Technologies the Best Single Digit Stock to Buy Now?
Yahoo News
over two weeks ago at finance.yahoo.com         
ARRAY Technologies Names Darin Green as Chief Revenue Officer for North America
Yahoo News
over three weeks ago at finance.yahoo.com         
Why Array Technologies Is Among the Best Renewable Energy Stocks to Buy?
Yahoo News
over a month ago at businesswire.com         
Colorados Life Sciences Ecosystem Raised 2.15 Billion in 2024
businesswire News
over a month ago at www.macroaxis.com         
Acquisition by Neil Manning of 5700 shares of Array Technologies at 5.21 subject to Rule 16b-3
Macroaxis News
over a month ago at news.google.com         
Array Technologies stock hits 52-week low at 5.51 - Investing.com
Google News at Macroaxis
over a month ago at gurufocus.com         
ARRAY Technologies and RP Surpass 6GW of Solar Power Deployed
Gurufocus Stories at Macroaxis
over a month ago at bizjournals.com         
Abq solar firm Arrays 3M investment lets robots do what they do best
bizjournals News
over two months ago at investing.com         
Array Technologies CEO Kevin Hostetler acquires 100,037 in stock
Investing News at Macroaxis
over a year ago at finance.yahoo.com         
Antibody Drug Conjugates Global Market Report 2023
Yahoo News
3 days ago at investing.com         
Vertex Pharmaceuticals SWOT analysis stock outlook amid pipeline progress
Investing News at Macroaxis
few days ago at thelincolnianonline.com         
My Legacy Advisors LLC Has 913,000 Stake in Vertex Pharmaceuticals Incorporated
news
few days ago at thelincolnianonline.com         
Integrated Investment Consultants LLC Raises Position in Vertex Pharmaceuticals Incorporated
news
six days ago at thelincolnianonline.com         
Gateway Investment Advisers LLC Lowers Holdings in Vertex Pharmaceuticals Incorporated
news
over a week ago at investing.com         
CRISPR Therapeutics SWOT analysis gene editing pioneers stock faces pivotal year
Investing News at Macroaxis
over a week ago at benzinga.com         
HHS Challenges Vertex Over Fertility Services Program Tied To Casgevy Gene Therapy, Says Company Is ...
benzinga news
over a week ago at zacks.com         
Here is What to Know Beyond Why Vertex Pharmaceuticals Incorporated is a Trending Stock
zacks News
over a week ago at benzinga.com         
Heres How Much 100 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth Today
benzinga news
over a week ago at finance.yahoo.com         
Box Delivers Intelligent Content Management to the Enterprise with New Enterprise Advanced Plan
Yahoo News
over a week ago at thelincolnianonline.com         
Forza Wealth Management LLC Acquires 49 Shares of Vertex Pharmaceuticals Incorporated
news
over a year ago at reuters.com         
Pfizer forecasts 2024 profit, revenue below Wall Street expectations
reuters
over a year ago at seekingalpha.com         
Pfizer stock slips as 2024 guidance disappoints
seekingalpha News
over a year ago at cnbc.com         
Why investors should only trade a name like Linde on fundamentals
cnbc News
over a year ago at finance.yahoo.com         
Were Interested To See How Seagen Uses Its Cash Hoard To Grow
Yahoo News
over a year ago at businesswire.com         
ADCETRIS Plus Novel Immunotherapy Combination Delivers 100 percent Progression Free Survival at 12 m...
businesswire News
over a year ago at businesswire.com         
ADCETRIS Plus Novel Immunotherapy Combination Delivers 100 percent Progression Free Survival at 12 m...
businesswire News
over a year ago at dragonflycap.com         
5 Trade Ideas for MondayArista, Comerica, Interactive Brokers, Seagen and Teck Resources
news
over a year ago at benzinga.com         
100 Invested In Seagen 20 Years Ago Would Be Worth This Much Today
benzinga news
over a year ago at businesswire.com         
TUKYSA in Combination with Antibody-Drug Conjugate ado-Trastuzumab Emtansine Improves Progression-Fr...
businesswire News
over a year ago at thelincolnianonline.com         
Seagen Inc. Receives 193.00 Average PT from Analysts
news
over a year ago at www.macroaxis.com         
Disposition of 49701 shares by Michael Wortley of Reata Pharmaceuticals subject to Rule 16b-3
Macroaxis News
over a year ago at news.google.com         
Reata Pharmaceuticals, Inc. Is Expected To Breakeven In The Near Future - Yahoo Finance
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
Reata Pharmaceuticals Research Coverage Started at StockNews.com
news
over a year ago at thelincolnianonline.com         
Reata Pharmaceuticals, Inc. Stock Holdings Trimmed by Swiss National Bank
news
over a year ago at thelincolnianonline.com         
StockNews.com Begins Coverage on Reata Pharmaceuticals
news
over a year ago at www.macroaxis.com         
Sale by Michael Wortley of 807 shares of Reata Pharmaceuticals
Macroaxis News
over a year ago at zacks.com         
Alimera Sciences Reports Q2 Loss, Lags Revenue Estimates
zacks News
over a year ago at zacks.com         
Entrada Therapeutics, Inc. Reports Q2 Loss, Misses Revenue Estimates
zacks News
over a year ago at Macroaxis         
Should you quit your Reata Pharmaceuticals (USA Stocks:RETA) holdings?
Macroaxis News
over a year ago at thelincolnianonline.com         
Reata Pharmaceuticals Cut to Neutral at LADENBURG THALMSH SH
news
3 days ago at businesswire.com         
REGN INVESTOR ALERT Bronstein, Gewirtz Grossman LLC Announces that Regeneron Pharmaceuticals, Inc. I...
businesswire News
few days ago at thelincolnianonline.com         
Regeneron Pharmaceuticals Provides Business Updates and Highlights from 43rd Annual J.P. Morgan Heal...
news
few days ago at gurufocus.com         
REGN INVESTOR ALERT Robbins Geller Rudman Dowd LLP Announces that Regeneron ...
Gurufocus Stories at Macroaxis
six days ago at patch.com         
51 CA Teens Awarded 2,000 In 2025 Regeneron Science Talent Search
patch News
six days ago at thelincolnianonline.com         
Regeneron Pharmaceuticals, Inc. Shares Sold by Boston Common Asset Management LLC
news
over a week ago at gurufocus.com         
Regeneron Pharmaceuticals, Inc. Securities Fraud Class Action Lawsuit Pending Contact Levi ...
Gurufocus Stories at Macroaxis
over a week ago at fortune.com         
Pharma giant Regeneron is spending 119.5M on the worlds largest, most diverse genetic database using...
news
over a week ago at gurufocus.com         
The Gross Law Firm Notifies Regeneron Pharmaceuticals, Inc. ...
Gurufocus Stories at Macroaxis
over a week ago at insidermonkey.com         
Jim Cramer on Regeneron Pharmaceuticals, Inc. Stock That Seems To Have Disappointed People. Bizarre
insidermonkey News
over a week ago at gurufocus.com         
REGN INVESTOR DEADLINE Robbins Geller Rudman Dowd LLP Announces that Regeneron ...
Gurufocus Stories at Macroaxis
few days ago at news.google.com         
Assenagon Asset Management S.A. Decreases Stock Position in PTC Therapeutics, Inc. - MarketBeat
Google News at Macroaxis
over a week ago at finance.yahoo.com         
Orsini the Exclusive Specialty Pharmacy Provider for Gene Therapy KEBILIDI
Yahoo News
over a week ago at finance.yahoo.com         
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635
Yahoo News
over a week ago at gurufocus.com         
PTC Therapeutics Inc Reports Strong 2024 Performance and Outlines 2025 Outlook
Gurufocus Stories at Macroaxis
over two weeks ago at www.macroaxis.com         
Disposition of 107 shares by Neil Almstead of PTC Therapeutics at 44.5 subject to Rule 16b-3
Macroaxis News
over two weeks ago at www.macroaxis.com         
Acquisition by Klein Matthew B. of 175000 shares of PTC Therapeutics at 46.54 subject to Rule 16b-3
Macroaxis News
over a month ago at gurufocus.com         
PTC Therapeutics to Present at J.P. Morgan Healthcare Conference
Gurufocus Stories at Macroaxis
over a month ago at gurufocus.com         
PTC Therapeutics Submits NDA for Vatiquinone to FDA for Friedreich Ataxia Treatment
Gurufocus Stories at Macroaxis
over a month ago at finance.yahoo.com         
The Global Medical Cannula Market Is Poised for Significant Growth USD 447.0 Million by 2034 at a 6....
Yahoo News
over a month ago at benzinga.com         
PTC Therapeutics Ends Utreloxastat Development After Rare Neurodegenerative Disease Trial Misses Goa...
benzinga news
3 days ago at insidermonkey.com         
Disposition of 19444 shares by Dubovsky Filip of Novavax subject to Rule 16b-3
insidermonkey News
over a week ago at finance.yahoo.com         
Moderna Dropped by 20 percent This Week -- Is It a Smart Buy Right Now?
Yahoo News
over a week ago at investors.com         
Moderna Has Lost 94 percent Of Its Value Over Four Years. Is It A Sell?
Investors Business Daily at Macroaxis
over a week ago at finance.yahoo.com         
Moderna shares tumble on slashed sales guidance
Yahoo News
over two weeks ago at benzinga.com         
Nvidia, Palantir, Ionq, Novavax, And Tesla Why These 5 Stocks Are On Investors Radars Today
benzinga news
over two weeks ago at finance.yahoo.com         
Novavax surges 35 percent this week, taking five-year gains to 171
Yahoo News
over two weeks ago at finance.yahoo.com         
Moderna stock seesaws as first US bird flu death puts vaccine development in focus
Yahoo News
over two weeks ago at investors.com         
Boston Scientific Surges On 900 Million Takeover Of Bolt Medical
Investors Business Daily at Macroaxis
over two weeks ago at benzinga.com         
Why Novavax Stock Is Rising
benzinga news
over two weeks ago at thelincolnianonline.com         
Novavax Target of Unusually High Options Trading
news
over a year ago at thelincolnianonline.com         
Mirati Therapeutics Now Covered by Analysts at StockNews.com
news
over a year ago at finance.yahoo.com         
Billionaire Joe Lewis Pleads Guilty in Insider Trading Case
Yahoo News
over a year ago at smh.com.au         
Billionaire pleads guilty in insider trading case with a link to an Australian giant
news
over a year ago at streetinsider.com         
Frances Sanofi to buy U.S. drugs project INBRX-101 for about 2.2 billion
Street Insider News
over a year ago at streetinsider.com         
Frances Sanofi to buy U.S. drugs project INBRX-101 for about 2.2 billion
Street Insider News
over a year ago at streetinsider.com         
Frances Sanofi to buy U.S. drugs project INBRX-101 for about 2.2 billion
Street Insider News
over a year ago at streetinsider.com         
Frances Sanofi to buy U.S. drugs project INBRX-101 for about 2.2 billion
Street Insider News
over a year ago at aol.com         
Frances Sanofi to buy U.S. drugs project INBRX-101 for about 2.2 billion
news
over a year ago at seekingalpha.com         
Mirati Therapeutics stock ticks higher amid Nasdaq delisting for sale to Bristol-Myers
seekingalpha News
over a year ago at thelincolnianonline.com         
Brokerages Set Mirati Therapeutics, Inc. PT at 60.00
news
just now at simplywall.st         
Jazz Pharmaceuticals investors are sitting on a loss of 20 percent if they invested a year ago
Simply Wall St News at Macroaxis
few days ago at forbes.com         
New York Jazz Club Smoke Celebrates 25 Years
Usa forbes News
over a week ago at aol.com         
NBA reschedules Lakers, Clippers games postponed to avoid L.A. wildfires
news
over a week ago at nypost.com         
New Orleans Jazz Festival 2025 lineup Lil Wayne, Dave Matthews, more
news
over a week ago at finance.yahoo.com         
Primrose Bio to Collaborate with Serum Institute of India to Develop a Novel Multi-Antigen Vaccine
Yahoo News
over two weeks ago at nypost.com         
Morgan Freeman and Al Green stun bargoers with soulful duet of Lets Stay Together on New Years Eve
news
over a month ago at finance.yahoo.com         
Debbies Dream Foundation Curing Stomach Cancer Celebrates a Year of Impactful Programs and Community...
Yahoo News
over a month ago at investing.com         
Akari Therapeutics appoints new CEO and board member
Investing News at Macroaxis
over a month ago at finance.yahoo.com         
Jazz Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Yahoo News
over a month ago at gurufocus.com         
Jazz Pharmaceuticals Announces CEO Succession Plan
Gurufocus Stories at Macroaxis
few days ago at finance.yahoo.com         
Why Johnson Johnson Is the Best Soaps and Cleaning Materials Stock to Invest In
Yahoo News
few days ago at finance.yahoo.com         
Why Intra-Cellular Therapies, Inc. Dominated Last Weeks Rally
Yahoo News
six days ago at gurufocus.com         
HAREHOLDER ALERT The MA Class Action Firm Is Investigating the Merger -- CCNE, ITCI, ...
Gurufocus Stories at Macroaxis
six days ago at finance.yahoo.com         
Mega MA at JP Morgan Conference 2025 is biopharma MA poised for a rebound?
Yahoo News
over a week ago at thelincolnianonline.com         
Intra-Cellular Therapies Hold Rating Reiterated at Needham Company LLC
news
over a week ago at finance.yahoo.com         
The Zacks Analyst Blog Highlights JJ, Eli Lilly, GSK and Intra-Cellular
Yahoo News
over a week ago at insidermonkey.com         
Why Intra-Cellular Led the Monday Upsurge?
insidermonkey News
over a week ago at finance.yahoo.com         
Why Intra-Cellular Led the Monday Upsurge?
Yahoo News
over a week ago at finance.yahoo.com         
JJ buys Intra-Cellular in 14.6 billion deal, delving further into central nervous system disorders
Yahoo News
over a week ago at businesswire.com         
Shareholder Alert Ademi LLP investigates whether Intra-Cellular Therapies, Inc. is obtaining a Fair ...
businesswire News
3 days ago at thelincolnianonline.com         
Iovance Biotherapeutics Sets New 52-Week Low Heres Why
news
six days ago at gurufocus.com         
Iovance Biotherapeutics Inc Announces Inducement Stock Options for New Employees
Gurufocus Stories at Macroaxis
six days ago at finance.yahoo.com         
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635
Yahoo News
over a week ago at news.google.com         
Disposition of 2813 shares by Igor Bilinsky of Iovance Biotherapeutics subject to Rule 16b-3
Google News at Macroaxis
over two weeks ago at fool.com         
Disposition of 7287 shares by Igor Bilinsky of Iovance Biotherapeutics at 16.96 subject to Rule 16b-...
fool News
over two weeks ago at finance.yahoo.com         
Why Iovance Biotherapeutics Stock Zoomed More Than 5 percent Higher Today
Yahoo News
over two weeks ago at thelincolnianonline.com         
Iovance Biotherapeutics Shares Up 7.7 percent Heres What Happened
news
over a month ago at gurufocus.com         
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635
Gurufocus Stories at Macroaxis
over a month ago at fool.com         
If I Could Only Buy 3 Stocks in the Last Month of 2024, Id Pick These
fool News
over a month ago at fool.com         
2 Growth Stocks That Could Rocket Higher in 2025 Are They Right for Your Portfolio?
fool News
over a year ago at news.google.com         
Form 485BPOS INSTITUTIONAL FIDUCIARY - StreetInsider.com
Google News at Macroaxis
3 days ago at finance.yahoo.com         
These 2 Medical Stocks Could Beat Earnings Why They Should Be on Your Radar
Yahoo News
six days ago at finance.yahoo.com         
Weekly Roundup 15 Health Press Releases You Need to See
Yahoo News
over a week ago at finance.yahoo.com         
If There Is a Monster in Loch Ness, This Geneticist Will Find It
Yahoo News
over a week ago at zacks.com         
Why Illumina is Poised to Beat Earnings Estimates Again
zacks News
over a week ago at newsweek.com         
How genes are mapping the way to cancer cures
news
over a week ago at investors.com         
IBD Rating Upgrades Illumina Shows Improved Technical Strength
Investors Business Daily at Macroaxis
over a week ago at finance.yahoo.com         
Conceivable Life Sciences Closes 18 Million Series A Financing to Advance Development and Commercial...
Yahoo News
over a week ago at finance.yahoo.com         
NVIDIA Showcases AI-Driven Healthcare Innovations at JPMorgan Conference
Yahoo News
over a week ago at gurufocus.com         
Illumina and NVIDIA Collaborate to Revolutionize Genomic Analysis with AI
Gurufocus Stories at Macroaxis
over a week ago at gurufocus.com         
Illumina Inc Stock Price Up 4.32 percent on Jan 13
Gurufocus Stories at Macroaxis
over a year ago at www.macroaxis.com         
Disposition of 110447 shares by Thomas Watkins of Horizon Pharma subject to Rule 16b-3
Macroaxis News
over a year ago at news.google.com         
Institutional owners may consider drastic measures as Vir Biotechnology, Inc.s recent US85m drop add...
Google News at Macroaxis
over a year ago at businesswire.com         
Horizon Therapeutics plc Rule 2.12 Announcement
businesswire News
over a year ago at benzinga.com         
Heres How Much 1000 Invested In Horizon Therapeutics 10 Years Ago Would Be Worth Today
benzinga news
over a year ago at news.google.com         
U.S. FTC allows Amgen to move forward with 27.8 bln Horizon deal - CNBC - Marketscreener.com
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
Toronto Dominion Bank Buys 185,145 Shares of Horizon Therapeutics Public Limited
news
over a year ago at finance.yahoo.com         
Horizon Up as FTC Pauses Acquisition by Amgen Lawsuit
Yahoo News
over a year ago at finance.yahoo.com         
Horizon Therapeutics plc Ranks First in Overall Corporate Reputation by Rare Disease Patient Advocac...
Yahoo News
over a year ago at marketwatch.com         
George Soros has a big stake in this stock but its posted a roughly 9 percent loss this year. Are th...
marketwatch News
over a year ago at thelincolnianonline.com         
Horizon Therapeutics Public Issues Earnings Results
news
3 days ago at finance.yahoo.com         
Why Gilead Sciences Outpaced the Stock Market Today
Yahoo News
few days ago at thelincolnianonline.com         
Cambridge Advisors Inc. Reduces Stock Holdings in Gilead Sciences, Inc.
news
few days ago at thelincolnianonline.com         
Whitener Capital Management Inc. Sells 120 Shares of Gilead Sciences, Inc.
news
six days ago at finance.yahoo.com         
B-cell Depletion Innovation Research Report 2024 Roche Dominate the Patent Activity in B-cell Deplet...
Yahoo News
over a week ago at gurufocus.com         
Insider Sell Andrew Dickinson Sells Shares of Gilead Sciences Inc
Gurufocus Stories at Macroaxis
over a week ago at finance.yahoo.com         
Is Trending Stock Gilead Sciences, Inc. a Buy Now?
Yahoo News
over a week ago at statnews.com         
Disposition of 2500 shares by Andrew Dickinson of Gilead Sciences at 91.35 subject to Rule 16b-3
news
over a week ago at seekingalpha.com         
Gilead reportedly settles CDC patent dispute over HIV drugs
seekingalpha News
over a week ago at finance.yahoo.com         
Form 8.3 - HOOKIPA Pharma Inc.
Yahoo News
over a week ago at kalkinemedia.com         
Gileads new HIV prevention drug lenacapavir will change the face of HIV, says CEO Daniel ODay
news
over six months ago at seekingalpha.com         
Ono Pharmaceutical completes tender offer for Deciphera
seekingalpha News
over six months ago at finance.yahoo.com         
Deciphera Pharmaceuticals Announces Oral Presentation of Results from MOTION Pivotal Phase 3 Study o...
Yahoo News
over six months ago at news.google.com         
Charles Schwab Investment Management Inc. Has 8.31 Million Position in Deciphera Pharmaceuticals, In...
Google News at Macroaxis
over six months ago at news.google.com         
Decipheras Shares Surge 74.3 percent in a Month Heres Why - Zacks Investment Research
Google News at Macroaxis
over six months ago at zacks.com         
Heres What Key Metrics Tell Us About Deciphera Pharmaceuticals Q1 Earnings
zacks News
over six months ago at news.google.com         
Deciphera Pharmaceuticals Investment Analysts Weekly Ratings Changes - Defense World
Google News at Macroaxis
over six months ago at finance.yahoo.com         
Biotech Stock Roundup GILDs GSK Q1 Earnings, DCPH Soars on Acquisition News More
Yahoo News
over six months ago at benzinga.com         
SHAREHOLDER INVESTIGATION Halper Sadeh LLC Investigates HRT, DCPH, UMBF
benzinga news
over six months ago at seekingalpha.com         
ONO to acquire Deciphera Pharmaceuticals in 2.4B deal
seekingalpha News
over six months ago at businesswire.com         
Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For 2.4 Billion
businesswire News
just now at kalkinemedia.com         
Japan gives priority review status to Alzheimers drug developed by Eisai, Biogen
news
six days ago at seekingalpha.com         
Sage sues Biogen in wake of 469M buyout offer report
seekingalpha News
over a week ago at bizjournals.com         
Biogen lays out three FDA decisions that could ramp up Alzheimers drug launch
bizjournals News
over a week ago at investing.com         
Biogen appoints new Chief Accounting Officer
Investing News at Macroaxis
over a week ago at seekingalpha.com         
Sarepta, Biogen drugs with accelerated approval under fire in FDA report
seekingalpha News
over a week ago at finance.yahoo.com         
Digital Neuro Biomarkers Market Research 2025-2030, Competitive Analysis of Altoida, Koneksa, Biogen...
Yahoo News
over a week ago at seekingalpha.com         
Biogen, Eisai Alzheimers injection gets FDA review
seekingalpha News
over a week ago at nbcnews.com         
Dementia risk may be twice as high as Americans live longer, study finds
news
over a week ago at finance.yahoo.com         
Biogen Insider Ups Holding During Year
Yahoo News
over a week ago at kalkinemedia.com         
Could Alzheimers treatment drugs be the next big investor opportunity after obesity pills?
news
six days ago at news.google.com         
Ascendis Pharma AS Stock Price Down 5.1 percent - Should You Sell - MarketBeat
Google News at Macroaxis
over a week ago at gurufocus.com         
Ascendis Pharma AS Announces Strategic Roadmap and Key Milestones for 2025
Gurufocus Stories at Macroaxis
over a week ago at gurufocus.com         
Ascendis Pharma AS Announces Strategic Roadmap and Key Milestones for 2025
Gurufocus Stories at Macroaxis
over two weeks ago at benzinga.com         
This Coca-Cola Analyst Begins Coverage On A Bullish Note Here Are Top 5 Initiations For Tuesday
benzinga news
over a month ago at zacks.com         
Sage Therapeutics Surges 12.2 percent Is This an Indication of Further Gains?
zacks News
over a month ago at globenewswire.com         
YORVIPATH Now Commercially Available in the United States for the Treatment of Hypoparathyroidism in...
Macroaxis News: globenewswire.com
over a month ago at investing.com         
BioMarins SWOT analysis rare disease leaders stock faces growth hurdles
Investing News at Macroaxis
over a month ago at gurufocus.com         
Ascendis Pharma AS Announces Positive Phase 2 Trial Results for TransCon hGH in Turner ...
Gurufocus Stories at Macroaxis
over a month ago at globenewswire.com         
FDA Accepts Ascendis Pharmas Supplemental Biologics License Application for TransCon hGH for the Tre...
Macroaxis News: globenewswire.com
over a month ago at finance.yahoo.com         
Er-Kim Extends Exclusive Distribution Agreement with Ascendis Pharma AS to Expand Commercialization ...
Yahoo News
few days ago at zacks.com         
Best Momentum Stocks to Buy for January 20th
zacks News
over a week ago at benzinga.com         
Heres How Much You Would Have Made Owning argenx Stock In The Last 5 Years
benzinga news
over a week ago at thelincolnianonline.com         
HC Wainwright Reiterates Buy Rating for argenx
news
over a week ago at gurufocus.com         
argenx SE Announces Preliminary 2024 Financial Results and Strategic Priorities for 2025
Gurufocus Stories at Macroaxis
over two weeks ago at gurufocus.com         
argenx to Present at 43rd Annual J.P. Morgan Healthcare Conference
Gurufocus Stories at Macroaxis
over three weeks ago at gurufocus.com         
argenx Announces Approval of VYVDURA in Japan for ...
Gurufocus Stories at Macroaxis
over a month ago at finance.yahoo.com         
Is Argenx SE the Best Performing Biotech Stock in 2024?
Yahoo News
over a month ago at news.google.com         
argenxs SWOT analysis biotech stock soars on VYVGART success - Investing.com
Google News at Macroaxis
over a month ago at investing.com         
Piper Sandler maintains stock target on argenx, cites growth potential
Investing News at Macroaxis
over a month ago at investing.com         
Immunovants SWOT analysis stock undervalued amid promising Graves disease treatment
Investing News at Macroaxis
3 days ago at businesswire.com         
Arcus Biosciences Appoints Richard Markus, M.D., Ph.D. as Chief Medical Officer
businesswire News
few days ago at insidermonkey.com         
Heres Why Amgen Inc. Is Among the Highest Yielding Dividend Stocks In the Dow
insidermonkey News
few days ago at finance.yahoo.com         
Why Is Amgen Inc. Among Louis Navelliers Top Long-term Stock Picks?
Yahoo News
few days ago at thelincolnianonline.com         
Acquisition by Ishrak Omar of 220 shares of Amgen subject to Rule 16b-3
news
six days ago at simplywall.st         
Amgens Upcoming Dividend Will Be Larger Than Last Years
Simply Wall St News at Macroaxis
over a week ago at thelincolnianonline.com         
Accurate Wealth Management LLC Increases Stock Position in Amgen Inc.
news
over a week ago at thelincolnianonline.com         
Flywheel Private Wealth LLC Acquires New Shares in Amgen Inc.
news
over a week ago at zacks.com         
NVO, VKTX Stocks Fall as Lillys Zepbound, Mounjaro Sales Slow Down
zacks News
over a week ago at finance.yahoo.com         
Why Amgen is a Top Momentum Stock for the Long-Term
Yahoo News
over a week ago at zacks.com         
Amgen Stock Falls Amid Market Uptick What Investors Need to Know
zacks News
3 days ago at finance.yahoo.com         
Nanobiotix Stock Gains as Dosing Begins in Mid-Stage NSCLC Study
Yahoo News
few days ago at thelincolnianonline.com         
BioMarin Pharmaceutical Inc. Receives Consensus Rating of Moderate Buy from Brokerages
news
six days ago at zacks.com         
IBRX Stock Soars on Completing Filing for Cancer Therapy in EU UK
zacks News
over a week ago at zacks.com         
5 Biotech Stocks Worth Adding to Your Portfolio in 2025
zacks News
over a week ago at zacks.com         
Wall Street Analysts Predict a 45.86 percent Upside in BioMarin Heres What You Should Know
zacks News
over a week ago at thelincolnianonline.com         
BioMarin Pharmaceutical Trading Up 2.4 percent Heres Why
news
over two weeks ago at finance.yahoo.com         
Heres Why BioMarin Pharmaceutical is a Strong Growth Stock
Yahoo News
over two weeks ago at finance.yahoo.com         
Zacks.com featured highlights include Leidos, Amazon.com, Halozyme Therapeutics and BioMarin Pharmac...
Yahoo News
over two weeks ago at gurufocus.com         
BioMarin Pharmaceutical Inc. to Present at J.P. Morgan Healthcare Conference
Gurufocus Stories at Macroaxis
over two weeks ago at finance.yahoo.com         
3 Reasons Why Growth Investors Shouldnt Overlook BioMarin
Yahoo News
just now at finance.yahoo.com         
Neurocrines Phase II schizophrenia trial fails to meet primary endpoint
Yahoo News
over a week ago at news.google.com         
Neurocrine Bio stock retains outperform rating on robust pipeline - MSN
Google News at Macroaxis
over a week ago at finance.yahoo.com         
Xenon Outlines Key Corporate Milestone Opportunities for 2025
Yahoo News
over two weeks ago at simplywall.st         
Neurocrine Biosciences shareholders have earned a 22 percent CAGR over the last three years
Simply Wall St News at Macroaxis
over two weeks ago at finance.yahoo.com         
Neurocrine Biosciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Yahoo News
over two weeks ago at medcitynews.com         
FDA Wraps Up 2024 Handing Out Several Notable Regulatory Decisions
news
over three weeks ago at finance.yahoo.com         
Schizophrenia Drug Market Forecast to 2031 The Entry of Adjunctive Therapies to Shape the Schizophre...
Yahoo News
over a month ago at zacks.com         
Enanta Pharmaceuticals Moves 7.2 percent Higher Will This Strength Last?
zacks News
over a month ago at gurufocus.com         
Neurocrine Biosciences Announces U.S. Launch of CRENESSITY for Classic Congenital Adrenal ...
Gurufocus Stories at Macroaxis
over a month ago at investing.com         
Disposition of 1091 shares by Ingrid Delaet of Neurocrine Biosciences at 135.0 subject to Rule 16b-3
Investing News at Macroaxis
over a year ago at news.google.com         
Netupitant Palonosetron FDC Market Size is Expected to Exhibit US 532228.43 million by 2028 Eisai Ph...
Google News at Macroaxis
over a year ago at news.google.com         
Content is king Digital materials linked to 2.5 times boost to new ... - FiercePharma
Google News at Macroaxis
3 days ago at simplywall.st         
Great week for Heron Therapeutics, Inc. institutional investors after losing 26 percent over the pre...
Simply Wall St News at Macroaxis
over a week ago at kalkinemedia.com         
How Could Petro Matads Heron-1 Well Revolutionize Oil Production in Mongolia?
news
over two weeks ago at thelincolnianonline.com         
StockNews.com Downgrades Heron Therapeutics to Hold
news
over a month ago at finance.yahoo.com         
1 Top Quantum Computing Stock to Buy Right Now
Yahoo News
over a month ago at ndtv.com         
Brazil Heron Flies After Rescuers Remove Plastic Cup From Its Throat
news
over a month ago at aol.com         
School pilot scheme to assess neurodivergent needs
news
over two months ago at bbc.co.uk         
Heron Foods Grimsby store must have security to sell alcohol
news
over two months ago at thelincolnianonline.com         
Heron Therapeutics Posts Earnings Results, Meets Expectations
news
over two months ago at gurufocus.com         
Heron Therapeutics Inc Q3 2024 Earnings Call Highlights Strategic Initiatives Drive ...
Gurufocus Stories at Macroaxis
over two months ago at insidermonkey.com         
Heron Therapeutics, Inc. Q3 2024 Earnings Call Transcript
insidermonkey News
Far too much social signal, news, headlines, and media speculation about Franklin Biotechnology that are available to investors today. That information is available publicly through Franklin media outlets and privately through word of mouth or via Franklin internal channels. However, regardless of the origin, that massive amount of Franklin data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Franklin Biotechnology news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Franklin Biotechnology relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Franklin Biotechnology's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Franklin Biotechnology alpha.

Other Information on Investing in Franklin Mutual Fund

Franklin Biotechnology financial ratios help investors to determine whether Franklin Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Franklin with respect to the benefits of owning Franklin Biotechnology security.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories